jQuery Mobile Framework
Search Home >> American Standards >> American Society for Testing Material (ASTM) >> ASTM F748-2006(2010) Standard Practice for Selecting Generic Biological Test Methods for Materials and Devices

ASTM F748-2006(2010) Standard Practice for Selecting Generic Biological Test Methods for Materials and Devices

Standard Number:  ASTM F748-2006(2010)
Title:  Standard Practice for Selecting Generic Biological Test Methods for Materials and Devices
Language:  English
Replacing Standard:  ASTM F748-2006

Execute Date:  2006/12/1
Status:  Superseded
International Classification for Standards (ICS)MATHEMATICS. NATURAL SCIENCES>>Biology. Botany. Zoology
CCS Classification for Standardscomprehensive>>Basic subjects>>Basic subjects comprehensive
Publisher:  American Society for Testing Material (ASTM)
Number of Pages:8P.;A4  


The objective of this practice is to recommend sufficient biological testing to establish a reasonable level of confidence concerning the biological response to a material or device, while at the same time avoiding unnecessary testing.

This practice is intended to provide guidance to the materials investigator in selecting the proper procedures to be carried out for the screening of new or modified materials. Because each material and each implant situation involves its own unique circumstances, these recommendations should be modified as necessary and do not constitute the only testing that will be required for a material nor should these guidelines be interpreted as minimum requirements for any particular situation. While an attempt has been made to provide recommendation for different implant circumstances, some of the recommended testing may not be necessary or reasonable for a specific material or application.

1.1 This practice recommends generic biological test methods for materials and devices according to end-use applications. While chemical testing for extractable additives and residual monomers or residues from processing aids is necessary for most implant materials, such testing is not included as part of this practice. The reader is cautioned that the area of materials biocompatibility testing is a rapidly evolving field, and improved methods are evolving rapidly, so this practice is by necessity only a guideline. A thorough knowledge of current techniques and research is critical to a complete evaluation of new materials.

1.2 These test protocols are intended to apply to materials and medical devices for human application. Biological evaluation of materials and devices, and related subjects such as pyrogen testing, batch testing of production lots, and so on, are also discussed. Tests include those performed on materials, end products, and extracts. Rationale and comments on current state of the art are included for all test procedures described.

1.3 The biocompatibility of materials used in single or multicomponent medical devices for human use depends to a large degree on the particular nature of the end-use application. Biological reactions that are detrimental to the success of a material in one device application may have little or no bearing on the successful use of the material for a different application. It is, therefore, not possible to specify a set of biocompatibility test methods which will be necessary and sufficient to establish biocompatibility for all materials and applications.

1.4 The evaluation of tissue engineered medical products (TEMPs) may, in some cases, involve different or additional testing beyond those suggested for non-tissue-based materials and devices. Where appropriate, these differences are discussed in this practice and additional tests described.

1.5 The ethical use of research animals places the obligation on the individual investigator to determine the most efficient methods for performing the necessary testing without undue use of animals. Where adequate prior data exists to substantiate certain types of safety information, these guidelines should not be interpreted to mean that testing should be unnecessarily repeated.

1.6 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory limitations prior to use.  

Cross References:ASTM E1202;ASTM E1262;ASTM E1263;ASTM E1280;ASTM E1397;ASTM E1398;ASTM F619;ASTM F719;ASTM F720;ASTM F749;ASTM F750;ASTM F756;ASTM F763;ASTM F813;ASTM F895;ASTM F981;ASTM F1027;ASTM F1408;ASTM F1439;ASTM F1877;ASTM F1903;ASTM F1904;ASTM F1905;ASTM F1906;ASTM F1983;ASTM F1984;ASTM F2065;ASTM F2147;ASTM F2148;ASTM F2151;ASTM F2382;Immunotoxicity Testing Guidance-FDA  
File Format:  PDF(Acrobat Reader) or Word version doc Document
File Size:  548KB
Tile in English:  Standard Practice for Selecting Generic Biological Test Methods for Materials and Devices

Full Text Information


Top 10

New 10

PC Version